Showing results (421-430 of 775) with videos related to

Sort By:
Pageof 78
The Journal of Dermatological Treatment|July 4, 2019
Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasisBoni Elewski, Alan Menter, Jeffrey Crowley, et al.
Journal of Drugs in Dermatology : JDD|January 14, 2009
Adverse drug events in infliximab-treated patients compared with the general and psoriasis populationsAlan Menter, Kristian Reich, Alice B Gottlieb, et al.
Physiological Genomics|March 20, 2003
Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide arrayXianghong Zhou, James G Krueger, Ming-Chih J Kao, et al.
The Journal of Dermatological Treatment|August 27, 2024
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)Brian S Kim, Jennifer A Mohawk, Sherri So, et al.
JAMA|December 18, 2003
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trialKenneth B Gordon, Kim A Papp, Tiffani K Hamilton, et al.
The Journal of Dermatological Treatment|May 1, 2019
US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis RegistryBruce E Strober, Rebecca Germino, Adriana Guana, et al.
The Journal of Dermatological Treatment|September 1, 2016
Patient-reported impact of chronic urticaria compared with psoriasis in theUnited StatesMeryl H Mendelson, Jonathan A Bernstein, Susan Gabriel, et al.
Pageof 78